XML 126 R33.htm IDEA: XBRL DOCUMENT v3.25.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
SCHEDULE OF RECONCILIATION OF INCOME TAX BENEFIT AT THE FEDERAL STATUTORY INCOME TAX RATE

A reconciliation of income tax benefit at the federal statutory income tax rate to the income tax expense at the Company’s effective income tax rate is as follows:

 

   2024   2023 
   Year Ended December 31, 
   2024   2023 
Federal benefit at statutory rate   21.0%   21.0%
Convertible note interest       (0.4)
Permanent differences   29.2    (17.4)
State taxes, net of federal benefit   12.3    2.2 
Change in valuation allowance   (66.5)   (5.4)
Stock based compensation   4.6     
Other   (0.6)    
Tax credits       0.1 
Income Tax Expense   %   %
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES

The following items comprise the Company’s net deferred tax assets and liabilities as of December 31, 2024 and December 31, 2023:

 

      2023 
   December 31, 
   2024   2023 
Deferred tax assets          
Net operating loss  $6,808,826   $3,755,008 
Accrued expenses and other   385,801    42,330 
Lease liability   61,380    127,427 
Stock-based compensation   6,110,942    718,425 
Fixed assets   33,834     
Other   30,823     
Capitalized research and development expenditures   2,944,801    2,589,105 
Research and development credits   234,478    317,455 
Total deferred tax assets   16,610,885    7,549,750 
Valuation allowance   (16,551,169)   (7,426,952)
Deferred tax assets   59,716    122,798 
Deferred tax liabilities:          
Right of use asset   (59,716)   (122,798)
Total deferred tax liabilities   (59,716)   (122,798)
Net deferred tax assets  $   $ 
SCHEDULE OF VALUATION ALLOWANCE FOR NET DEFERRED TAX ASSETS

A summary of changes in the valuation allowance for net deferred tax assets during the year ended December 31, 2024 and 2023 were as follows:

 

   2024   2023 
   Year Ended December 31, 
   2024   2023 
Valuation allowance  $7,426,952   $4,175,241 
Increases recorded to income tax provision   9,124,217    3,251,711 
Valuation allowance  $16,551,169   $7,426,952